Condition: Infection Due to Carbapenem Resistant Acinetobacter · Sponsor: Chiang Mai University
The goal of this clinical trial is to evaluate the efficacy of colistin compared with colistin plus fosfomycin against carbapenem-resistant Acinetobacter baumanii infection in Thailand. The main questions it aims to answer the following main questions: 1. Which group has better clinical response at end of treatment 2. Which group has better clinical response at 72 hours and micrological cure at 72 hours and at end of treatment
This description comes directly from the study's public registry record.
Athitaya Luangnara · 0954970567 · fenejung2@gmail.com
Parichat Salee · 0817830755 · parichat.pimsarn@gmail.com
Always discuss trial participation with your own doctor first.
| Faculty of medicine, Chiang Mai university | Chiang Mai, Thailand | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06570850